REQUEST FOR WHITE PAPERS BAA TOPIC: Topic 13. Biotechnology, “Controlling polymicrobial environments as a strategy for defeating harmful organisms while promoting the growth of beneficial organisms”

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W6QK ACC CCDC STTC

Contract Value

Not provided

Codes & Classification
Solicitation Number

W912CG-26-S-BIOTECH

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AJ11

Additional Details
Set Aside

NONE

Place of Performance

-

SourceSAM
Documents3
The U.S. Army Combat Capabilities Development Command (DEVCOM) Soldier Center, Soldier Effectiveness Directorate, Biological Science & Technology Branch, is seeking innovative research concepts through a Sources Sought Notice for White Papers under Broad Agency Announcement (BAA) W911QY-25-R-0023, specifically addressing Topic 13: Biotechnology—“Controlling polymicrobial environments as a strategy for defeating harmful organisms while promoting the growth of beneficial organisms.” This initiative is part of the Fiscal Year 2026-2027 (FY26-27) Biotechnology Topic Area and aims to advance scientific knowledge and develop practical solutions to enhance Warfighter health and operational readiness. **Purpose and Scope** The primary focus of this procurement is to address the high incidence of urinary tract infections (UTIs) among female Warfighters, particularly in austere environments where hygiene facilities are limited. Current mitigation strategies, such as hygiene training and hydration, have proven insufficient, with incident rates exceeding 30% and 12% experiencing recurrent infections. The Army seeks to develop a preventative approach using hygiene wipes impregnated with bacteriophage (phage) targeting UTI-causing E. coli, which accounts for 80% of cases. Unlike broad-spectrum antibiotics, phage therapy offers targeted action, preserving beneficial organisms essential for urogenital health. The intended outcome is the design, development, and testing of a phage-friendly formulation for prototype cosmetic hygiene wipes that maintain phage activity under extreme thermal conditions. The project encompasses formulation optimization, stability testing, prototype production, and regulatory compliance, ultimately delivering a product that can be deployed in challenging operational settings. **Key Requirements and Objectives** Offerors are expected to: - Develop up to three formulation iterations for phage hygiene wipes, optimizing for thermal stability and compatibility with phage viability. - Utilize components such as phage storage buffers, preservatives effective at neutral pH, potentiators, emollients, humectants, and other cosmetic additives, ensuring none inhibit phage titer or stability. - Conduct rigorous testing, including freeze/thaw cycles, accelerated heat stability, preservative challenge tests, and Human Repeated Insult Patch Tests (HRIPT). - Produce prototype wipes (50 soft packs of 15 wipes each with phage, and 50 packs with formulation only), using natural/cellulosic materials and phage-friendly packaging. - Ensure compliance with the Modernization of Cosmetic Regulation Act (MoCRA), including preservative challenge testing and ingredient toxicity assessments. **Expected Deliverables** - Optimized phage wipe formulation maintaining thermal stability and phage viability. - Prototype wipe packages for evaluation, delivered under specified conditions. - Documentation of testing results and regulatory compliance assessments. **Contracting Entity and Contact Information** The contracting entity is W6QK ACC CCDC STTC, a federal office under the Department of Defense, Department of the Army. The primary location for submission and correspondence is the U.S. Army Natick Soldier Systems Center, 15 General Greene Avenue, Natick, MA 01760-5020. Primary contacts for administrative and submission inquiries are: - Mr. Matthew Whipple, (508) 206-3803, [email protected] - Ms. Jennifer Rourke, (508) 206-3853, [email protected] Technical points of contact include: - Steven Arcidiacono, [email protected], (520) 714-3235 - Ids Pantoja Feliciano de Goodfellow, [email protected], (520) 713-8083 **Classification Codes and Procurement Details** - NAICS Code: 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) - Product Service Code: AJ11 - Set-Aside Type: None (full and open competition) - Procurement Identifier: W912CG-26-S-BIOTECH **Procurement Type and Process** This is a Broad Agency Announcement (BAA) under FAR 6.102(d)(2), seeking exploratory research and development proposals. The process begins with the submission of White Papers, which must be received electronically by 31 August 2026, 5:00 P.M. EDT. Only unclassified White Papers will be accepted, and submission is a prerequisite for eligibility to submit a formal proposal. The Government intends to award a BAA contract, though other instrument types (grant, cooperative agreement) are possible. White Papers should not exceed five pages and must include a technical explanation, management description, past performance, and estimated cost/schedule. Evaluation criteria include scientific/technical merit, management approach, importance to agency programs, and proposed cost/price. Only concepts for research/exploratory development will be considered; requests for conference support, consulting, engineering, marketing, or training services are excluded. **Special Considerations** - No set-aside is specified; the opportunity is open to all qualified entities. - Only a government contracting or grants officer can obligate the government to any agreement involving expenditure of funds. - The Government reserves the right to cancel the requirement at any time and is not liable for proposal preparation costs. - Communication with technical POCs is permitted prior to formal proposal submission; after submission, no further communication is allowed. **Constant Elements Over Contract Lifecycle** - The focus on advancing biotechnology for controlling polymicrobial environments and promoting Warfighter health. - The requirement for compliance with regulatory standards and rigorous scientific evaluation. - The engagement with DEVCOM Soldier Center and adherence to Army mission objectives. - The competitive, open nature of the procurement process and evaluation based on merit and alignment with agency priorities. **Summary for Contractors** This opportunity is well-suited for organizations with expertise in biotechnology, phage therapy, cosmetic formulation, and product development for military or austere environments. The scope is research-driven, with a clear pathway from concept development to prototype delivery and regulatory compliance. Contractors should assess their capabilities in formulation science, stability testing, and regulatory affairs, as well as their experience in delivering innovative solutions for health and hygiene in challenging operational contexts. The Army seeks partners who can contribute to advancing the state of the art in targeted microbial control, supporting Warfighter readiness and health. For further details and submission instructions, refer to the official notice at [SAM.gov](https://sam.gov/opp/2bca17f2fa4b4187bad6c59d907b2dca/view).